Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 4/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9187620 | 0.90 | TDP1 (0.39) | TDP1CYP3A4ESR1ESR2TRPA1 | |
| SCHEMBL8652282 | 0.85 | KCNH2 (0.41) | TDP1CYP3A4ALDH1A1TSHRKDM4E | |
| SCHEMBL5003760 | 0.85 | KCNH2 (0.41) | TDP1CYP3A4ALDH1A1TSHRKDM4E | |
| SCHEMBL9190955 | 0.83 | CYP3A4 (0.43) | TDP1CYP3A4ESR1ESR2CALM1 | |
| SCHEMBL7067524 | 0.82 | HTT (0.41) | TDP1CYP3A4ALDH1A1TSHRKDM4E | |
| SCHEMBL5000276 | 0.82 | HTR1A (0.39) | — | |
| SCHEMBL6245326 | 0.80 | CYP3A4 (0.32) | TDP1CYP3A4ALDH1A1TSHR | |
| SCHEMBL8655836 | 0.79 | ALDH1A1 (0.42) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL7034470 | 0.79 | CYP3A4 (0.39) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL5003993 | 0.79 | MEN1 (0.46) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3921298-B1 | PROCESS FOR THE PRODUCTION OF ACETALS FROM CARBON DIOXIDE | BASF SE (DE) | 2025-12-03 | — | — | EP | claimed |
| US-12172953-B2 | Process for the production of acetals from carbon dioxide | BASF SE (DE) | 2024-12-24 | — | — | US | claimed |
| WO-2023152245-A1 | TRANSITION METAL-CATALYSED DISASSEMBLY OF EPOXY-BASED POLYMERS AND FIBRE-REINFORCED COMPOSITES THEREOF | AARHUS UNIVERSITET (DK) | 2023-08-17 | — | — | WO | claimed |
| US-20220119332-A1 | PROCESS FOR THE PRODUCTION OF ACETALS FROM CARBON DIOXIDE | BASF SE (DE) | 2022-04-21 | — | — | US | claimed |
| CN-113423682-A | Process for producing acetals from carbon dioxide | 巴斯夫欧洲公司 | 2021-09-21 | — | — | CN | claimed |
| WO-2015121357-A1 | METHOD FOR HYDROGENATING CARBON DIOXIDE INTO FORMAMIDES | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2015-08-20 | — | — | WO | claimed |
| US-20140255296-A1 | METHOD FOR OBTAINING HYDROGEN BY CATALYTIC DECOMPOSITION OF FORMIC ACID | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2014-09-11 | — | — | US | claimed |
| EP-2699513-A1 | METHOD FOR OBTAINING HYDROGEN BY CATALYTIC DECOMPOSITION OF FORMIC ACID | Bayer Technology Services GmbH (DE) | 2014-02-26 | — | — | EP | claimed |
| WO-2012143372-A1 | METHOD FOR OBTAINING HYDROGEN BY CATALYTIC DECOMPOSITION OF FORMIC ACID | LEIBNIZ-INSTITUT FÜR KATALYSE E.V. AN DER UNIVERSITÄT ROSTOCK (DE) | 2012-10-26 | — | — | WO | claimed |
| US-20260139118-A1 | METHOD FOR THE DEGRADATION OF EPOXY HYBRID RESIN | EVONIK OPERATIONS GMBH (DE) | 2026-05-21 | — | — | US | disclosed |
| EP-4745185-A1 | METHOD FOR DEGRADING EPOXY HYBRID RESIN | Evonik Operations GmbH (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-3921298-B1 | PROCESS FOR THE PRODUCTION OF ACETALS FROM CARBON DIOXIDE | BASF SE (DE) | 2025-12-03 | — | — | EP | disclosed |
| EP-4590417-A1 | PROCESS FOR REMOVING WATER FROM A MIXTURE CONTAINING METHANOL, WATER AND A CATALYST SYSTEM | BASF SE (DE) | 2025-07-30 | — | — | EP | disclosed |
| EP-4590418-A1 | WATER REMOVAL IN A PROCESS FOR PREPARING METHYLAL FROM CARBON DIOXIDE | BASF SE (DE) | 2025-07-30 | — | — | EP | disclosed |
| EP-2699513-A1 | METHOD FOR OBTAINING HYDROGEN BY CATALYTIC DECOMPOSITION OF FORMIC ACID | Bayer Technology Services GmbH (DE) | 2014-02-26 | — | — | EP | disclosed |
| WO-2012143372-A1 | METHOD FOR OBTAINING HYDROGEN BY CATALYTIC DECOMPOSITION OF FORMIC ACID | LEIBNIZ-INSTITUT FÜR KATALYSE E.V. AN DER UNIVERSITÄT ROSTOCK (DE) | 2012-10-26 | — | — | WO | disclosed |
| EP-0788405-A1 | CATALYST FOR THE PREPARATION OF LINEAR CARBON MONOXIDE/ALPHA-OLEFIN COPOLYMERS | THE DOW CHEMICAL COMPANY (US) | 1997-08-13 | — | — | EP | disclosed |
| US-5565547-A | Catalyst for the preparation of linear carbon monoxide/alpha-olefin copolymers | THE DOW CHEMICAL COMPANY (US) | 1996-10-15 | — | — | US | disclosed |
| US-5554777-A | Catalyst for the preparation of linear carbon monoxide/alpha-olefin copolymers | THE DOW CHEMICAL COMPAMY (US) | 1996-09-10 | — | — | US | disclosed |
| WO-1996001690-A1 | CATALYST FOR THE PREPARATION OF LINEAR CARBON MONOXIDE/ALPHA-OLEFIN COPOLYMERS | THE DOW CHEMICAL COMPANY (US) | 1996-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139118-A1 | METHOD FOR THE DEGRADATION OF EPOXY HYBRID RESIN | RPS20, RPS10, SMARCC2 | TDP1 4387/4885CYP3A4 1378/4885ESR1 332/4885 |
| US-12172953-B2 | Process for the production of acetals from carbon dioxide | CA4, CA2, CA3 | TDP1 4719/4885CYP3A4 1643/4885ESR1 1854/4885 |
| US-20220119332-A1 | PROCESS FOR THE PRODUCTION OF ACETALS FROM CARBON DIOXIDE | CA4, CA2, CA3 | TDP1 4719/4885CYP3A4 1643/4885ESR1 1854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.